Featured Topics

Children’s responds to ongoing court battle on federal funds for embryonic stem cell research

Update: On April 29, 2011, the U.S. Appeals Court vacated the injunction. To learn more about the current situation, please read the following two Vector blog posts from May 2011:


On August 23, 2010, an injunction was issued forbidding the use of federal funds to support embryonic stem cell research. A temporary stay was granted on September 9, but the issue is not closed: an appeals court will consider the case on September 20.

A halting of federal funds would threaten the progress of our work and dash the hopes of patients and their families facing illnesses who will someday benefit from this research. Experiments and studies currently being supported with federal grant dollars would depend upon support from private donations, and in these difficult economic times, full dependence on philanthropy as our sole source for funding is not realistic.  A court decision permanently halting these funds would be a tragic setback not only for  the  field of stem cell research, but most importantly for the patients for whom that research holds hope.

We are pleased with the court’s decision to issue a stay of the injunction and hope the ultimate outcome of this issue will be to reaffirm the use of federal funds to support embryonic stem cell research.

Leonard Zon, MD and George Q. Daley, MD, PhD

For more information, read Dr. Zon’s September 13, 2010 CNN op-ed on this topic.

Giving

Spotlight

  • Obama Stem Cell Policy Halted

    August 24, 2010 – A federal judge blocked President Obama’s 2009 executive order which expanded embryonic stem cell research, saying it violated a ban on federal money being used to destroy embryos. Children’s George Q. Daley, MD, PhD, responds in The New York Times.

  • One family’s story

    Andres Treviño, whose son has a rare immune disorder, explains why he and his wife donated embryos to stem cell research. Using these embryos, scientists were able to make embryonic stem cells for research purposes, carrying the same gene defect that caused the boy’s immune disease.